These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study. Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599 [TBL] [Abstract][Full Text] [Related]
3. Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments. Visser AG; van den Aardweg GJ; Levendag PC Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):497-505. PubMed ID: 8567354 [TBL] [Abstract][Full Text] [Related]
4. [The radiobiology of gynecologic HDR and LDR afterloading technics]. Bauer M; Schulz-Wendtland R Rontgenblatter; 1989 Jan; 42(1):54-6. PubMed ID: 2645638 [TBL] [Abstract][Full Text] [Related]
5. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix. Kim WC; Kim GE; Suh CO; Loh JJ Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597 [TBL] [Abstract][Full Text] [Related]
6. Constraints in the use of repair half times and mathematical modelling for the clinical application of HDR and PDR treatment schedules as an alternative for LDR brachytherapy. Pop LA; van den Broek JF; Visser AG; van der Kogel AJ Radiother Oncol; 1996 Feb; 38(2):153-62. PubMed ID: 8966228 [TBL] [Abstract][Full Text] [Related]
7. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer. Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473 [TBL] [Abstract][Full Text] [Related]
8. High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations. Stitt JA; Fowler JF; Thomadsen BR; Buchler DA; Paliwal BP; Kinsella TJ Int J Radiat Oncol Biol Phys; 1992; 24(2):335-48. PubMed ID: 1526873 [TBL] [Abstract][Full Text] [Related]
9. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience. Petereit DG; Sarkaria JN; Potter DM; Schink JC Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322 [TBL] [Abstract][Full Text] [Related]
10. High dose rate gynecological applications--radiobiological considerations based on the alpha-beta model. Ling CC; Sahoo N; Leibel S; Anderson LL Radiother Oncol; 1992 Oct; 25(2):103-10. PubMed ID: 1438929 [TBL] [Abstract][Full Text] [Related]
11. Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer. Murray L; Mason J; Henry AM; Hoskin P; Siebert FA; Venselaar J; Bownes P; Radiother Oncol; 2016 Aug; 120(2):293-9. PubMed ID: 27370205 [TBL] [Abstract][Full Text] [Related]
12. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma. Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728 [TBL] [Abstract][Full Text] [Related]
13. High dose rate versus low dose rate brachytherapy in the treatment of tongue carcinoma - a radiobiological study. Petera J; Matula P; Paluska P; Sirak I; Macingova Z; Kasaova L; Frgala T; Hodek M; Vosmik M Neoplasma; 2009; 56(2):163-8. PubMed ID: 19239332 [TBL] [Abstract][Full Text] [Related]
14. Dosimetric and radiobiological comparison of volumetric modulated arc therapy, high-dose rate brachytherapy, and low-dose rate permanent seeds implant for localized prostate cancer. Yang R; Zhao N; Liao A; Wang H; Qu A Med Dosim; 2016; 41(3):236-41. PubMed ID: 27400663 [TBL] [Abstract][Full Text] [Related]
15. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer. Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Nucletron and ROCS brachytherapy treatment planning systems for LDR and HDR applications. Ho AK; Sibata CH; Shin KH Med Dosim; 1994; 19(3):147-9. PubMed ID: 7818754 [TBL] [Abstract][Full Text] [Related]
18. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models. King CR Brachytherapy; 2002; 1(4):219-26. PubMed ID: 15062170 [TBL] [Abstract][Full Text] [Related]
19. High dose rate versus low dose rate brachytherapy for squamous cell carcinoma of the cervix: an economic analysis. Jones G; Lukka H; O'Brien B Br J Radiol; 1994 Nov; 67(803):1113-20. PubMed ID: 7820405 [TBL] [Abstract][Full Text] [Related]
20. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]